Spinal Muscular Atrophy Patient Recruitment

The UBC Gene Therapy Registry Team undertook a highly successful collaboration in the conduct of a prospective observational registry of patients with Spinal Muscular Atrophy (SMA). The program successfully enrolled approximately 300 patients into the global registry within an initial two-year period. Read about the results in the available case study.